Catalogo dei prodotti della ricerca

PATTI, FRANCESCO PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 803
EU - Europa 189
AS - Asia 158
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.164
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 797
IT - Italia 89
SG - Singapore 78
IN - India 49
CN - Cina 21
SE - Svezia 21
IE - Irlanda 17
BG - Bulgaria 13
FI - Finlandia 12
TG - Togo 9
GB - Regno Unito 7
ID - Indonesia 7
DE - Germania 6
CA - Canada 5
NL - Olanda 5
UA - Ucraina 5
CZ - Repubblica Ceca 4
EU - Europa 3
RO - Romania 3
RU - Federazione Russa 3
EG - Egitto 2
PL - Polonia 2
TR - Turchia 2
CH - Svizzera 1
GR - Grecia 1
HK - Hong Kong 1
MX - Messico 1
Totale 1.164
Salva come PNG Salva come JPEG
Città #
Fairfield 156
Chandler 69
Woodbridge 58
Singapore 56
Ashburn 55
Cambridge 51
Houston 51
Seattle 50
Wilmington 46
Princeton 29
Rome 29
Santa Clara 25
Dublin 17
Ann Arbor 15
Plano 15
Boston 13
San Diego 13
Sofia 13
Beijing 11
Norwalk 10
Helsinki 9
Lomé 9
Jakarta 7
New York 7
Dearborn 6
Lawrence 6
San Paolo di Civitate 6
Milan 5
Millbury 5
Palermo 5
Toronto 5
Andover 4
Fasano 4
Naples 4
Boardman 3
Brno 3
London 3
Moscow 3
Bühl 2
Calcio 2
Catania 2
Des Moines 2
Falls Church 2
Giza 2
Lappeenranta 2
Nanjing 2
Towson 2
Trento 2
Venezia 2
Vicenza 2
Warsaw 2
Amsterdam 1
Athens 1
Bergamo 1
Chiampo 1
Cles 1
Falkenstein 1
Fort Worth 1
Frankfurt am Main 1
Fremont 1
Grafing 1
Grottaglie 1
Guangzhou 1
Hong Kong 1
Jacksonville 1
Kunming 1
Lucca 1
Mannheim 1
Newark 1
Prescot 1
Prineville 1
Pune 1
San Mateo 1
Shenyang 1
Siena 1
Solan 1
Stockholm 1
Wandsworth 1
Washington 1
Wuhan 1
Zurich 1
Totale 932
Salva come PNG Salva come JPEG
Nome #
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis 103
Genetic burden of common variants in progressive and bout-onset multiple sclerosis 71
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 63
Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up 60
null 60
null 54
null 53
Disease-modifying therapies and coronavirus disease 2019 severity in multiple sclerosis 53
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs 52
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies 50
null 48
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: A prospective observational multicentric study 46
null 44
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register 37
MIGLIOR POSTER PREVENZIONE ED IGIENE DENTALE 2 CONGRESSO NAZIONALE DEI DOCENTI DI DISCIPLINE ODONTOSTOMATOLOGICHE 37
null 36
null 33
Sars-CoV2 infection in pregnant women with multiple sclerosis 28
null 28
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 26
Prognostic indicators in pediatric clinically isolated syndrome 23
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 23
Evaluation of drivers of treatment switch in relapsing multiple sclerosis. A study from the Italian MS Registry 21
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 21
Relapse-associated worsening in a real-life multiple sclerosis cohort: The role of age and pyramidal phenotype 19
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis 19
Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis 19
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study 17
null 14
Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach (Neurological Sciences, (2017), 38, 10, (1849-1858), 10.1007/s10072-017-3081-8) 14
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 14
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 13
Late-onset multiple sclerosis. Disability trajectories in relapsing-remitting patients of the Italian MS Registry 12
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study 12
The use of immunosuppressant therapy for multiple sclerosis in Italy: A multicenter retroprospective study 10
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 9
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis 8
Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach 6
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 5
null 3
COVID-19 severity in multiple sclerosis 2
Totale 1.266
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.400
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020187 0 0 0 0 0 28 44 36 35 19 20 5
2020/2021110 5 11 3 5 1 0 3 7 19 37 9 10
2021/2022191 20 11 14 7 40 9 1 19 13 8 14 35
2022/2023212 40 21 1 34 21 20 6 13 32 1 8 15
2023/2024176 13 19 8 17 8 25 16 13 3 30 14 10
2024/2025162 13 13 14 27 41 54 0 0 0 0 0 0
Totale 1.266